Munro J, Hurlbert B J, Hill G E
Department of Anesthesiology, University of Nebraska Medical Center, Omaha 68198-4455, USA.
Can J Anaesth. 1995 Mar;42(3):228-30. doi: 10.1007/BF03010683.
Phaeochromocytoma has traditionally been managed by preoperative adrenergic blockade followed by surgical devascularization and excision. Recently, various studies have reported the use of calcium channel blocking drug therapy, either as monotherapy or in combination with other non-adrenergic blocking antihypertensive medications for blood pressure control in the preoperative management of phaeochromocytoma. In this case report, diltiazem as monotherapy was used to establish adequate preoperative blood pressure control in a patient with metastatic phaeochromocytoma to the liver. During cryoablation therapy surgery of the liver metastasis, the patient demonstrated extreme blood pressure lability requiring nitroprusside and high end tidal concentrations of isoflurane for blood pressure control. This case report suggests that during resection of a phaeochromocytoma where tumour devascularization is not obtainable, calcium channel blocking drugs as monotherapy may be inadequate to control blood pressure extremes. The authors suggest that under clinical circumstances reported above strong consideration be given to the use of standard adrenergic blocking drug therapy pre- and intraoperatively.
传统上,嗜铬细胞瘤的治疗方法是术前进行肾上腺素能阻断,随后进行手术去血管化和切除。最近,各种研究报告了使用钙通道阻滞剂药物治疗,无论是作为单一疗法还是与其他非肾上腺素能阻断抗高血压药物联合使用,用于嗜铬细胞瘤术前管理中的血压控制。在本病例报告中,地尔硫䓬作为单一疗法用于对肝转移的嗜铬细胞瘤患者进行充分的术前血压控制。在肝转移灶的冷冻消融治疗手术期间,患者表现出极端的血压波动,需要硝普钠和高呼气末浓度的异氟醚来控制血压。本病例报告表明,在无法实现肿瘤去血管化的嗜铬细胞瘤切除术中,钙通道阻滞剂作为单一疗法可能不足以控制极端血压。作者建议,在上述临床情况下,应强烈考虑在术前和术中使用标准的肾上腺素能阻断药物治疗。